Keats Nelms

Keats Nelms serves as the Executive Director of Science Operations at Samsara Eco since January 2024, following extensive experience at The Australian National University, where roles included Chief of Research & Innovation Services and Pro-Vice Chancellor of Innovation (Acting). Previously, Keats co-founded and led Beta Therapeutics Pty. Ltd. as CEO, focusing on therapeutics for inflammatory conditions and diabetes. Other significant positions include Director at Canberra Innovation Network and Phenomix Corporation, along with senior roles at Mylexa Pty. Ltd. and Searle. Academic credentials encompass a Ph.D. in Biochemistry from the University of Minnesota Medical School and a Fulbright Fellowship in molecular biology from the University of Cambridge.